Immunocore Holdings (IMCR) Prepaid Assets (2020 - 2026)
Immunocore Holdings (IMCR) posted quarterly Prepaid Assets of $69.6 million for Q1 2026, up 66.89% year-on-year from $41.7 million in Q1 2025, and up 34.16% on a QoQ basis from $51.9 million in Q4 2025.
Immunocore Holdings (IMCR) Prepaid Assets (2020 - 2026) Analysis & Trends
Immunocore Holdings (IMCR) has reported Prepaid Assets for 7 consecutive years, with $69.6 million the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets rose 66.89% year-over-year to $69.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69.6 million (up 66.89% YoY) and the FY2025 annual result came in at $51.9 million, up 26.41% from the prior year.
- Prepaid Assets climbed to $69.6 million in Q1 2026 per IMCR's latest filing, from $51.9 million in the prior quarter.
- Over the last five years, Prepaid Assets for IMCR reached as high as $69.6 million in Q1 2026 and fell as low as $7.3 million in Q4 2022.
- A 5-year average of $39.6 million and a median of $41.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets soared 302.87% — and 2025, when it grew 26.41%.
- Year by year, Prepaid Assets stood at $7.3 million in 2022, then surged by 302.87% to $29.6 million in 2023, then surged by 38.62% to $41.0 million in 2024, then climbed by 26.41% to $51.9 million in 2025, then jumped by 34.16% to $69.6 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $69.6 million, $51.9 million, and $49.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immunocore Holdings | 1.80 Bn | 957.43 Mn | 106.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.59 Mn |
| Dec 31, 2025 | 51.87 Mn |
| Sep 30, 2025 | 48.96 Mn |
| Jun 30, 2025 | 44.27 Mn |
| Mar 31, 2025 | 41.70 Mn |
| Dec 31, 2024 | 41.03 Mn |
| Sep 30, 2024 | 36.45 Mn |
| Jun 30, 2024 | 33.56 Mn |
| Mar 31, 2024 | 31.30 Mn |
| Dec 31, 2023 | 29.60 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Dec 31, 2021 | 5.37 Mn |
| Dec 31, 2020 | 4.53 Mn |